Abstract  by unknown
J February1997 ABSTRACTS-Poster 277A
was conducted in 2792pta to evaluatefor further benefits in lower-risk
pts. Randomization was to placebo with standard-dose heparin, c7E3 with
standard-dose heparin, or c7E3 with low-dose (LD) heparin. Pta were cat-
egorized as having unstable angina, stable ischemia, or recent myocardial
infarction (Ml). Pts with a recent Ml were more likely to be male, younger,
and smokers, and were less likely to have diabetes, hypertension, or hy-
percholesterolemia (all p < 0.05). The primary endpoint by indication and
treatment group occurred as shown in the figure.
Coupled with the EPIC high-risk pt results, these data suggest that all pts
undergoing coronary intervention benefit from c7E3 treatment.
EJ9932 The Relationship Between Dissection Grade&Coronary Blood Flow as well as Other Angiographic
Outcomes After PTCA
K. Ryan, M. Rizzo, C. McLean, 1.Dotani, M. Goel, S. Marble, E. A1-Mousa,
W. Oaley,T. Dodge, M. Gibson, for the RESTORE lnVeSti9at0rS.WeSt.
Roxbury VAMC, Brigham & Women’s Hospital, Boston MA, USA
The relationship between post PTCA dissection grade & angiographic out-
comes wasexaminedin the RESTORE trial of Timfiban + heparln vs heparin
alone for 36 hrs. post PTCA in pts with acute coronary syndromes. The
frames fordyeto reach standardized distal Iandmarkawere counted to arrive
at the previously described Corrected TIMI Frame Count (CTFC), an index of
coronary flow. If no post PTCAdissection was present, the post PTCA CTFC
was 17.9 + 10.3, n = 818, whioh did not differ from the peat PTCA CTFC if a
mild dlssecfion (NHLBI type A = non-persistent Intraluminal radiolucency or
B = parallel tracts without peraietence) was present (18.2& 9.5, n = 228, p =
NS). The post PTCA CTFC of artefies with a severe dissection (NHLBI type
C = contrast outside lumen; D = spiral filling detect) was slower (21.4+ 13.7,
n = 69) than no dissection (p = 0.008) or mild dissection (p = 0.03). The risk
of abrupt clo.$ufewas higher in arteriea with typaa C/D dissection (10/112,
8.9%) than arteries with type A/B (6/363, 1.7%) or no dissection (17/1204,
1.4%)(P < 0.05). In contrast, the risk of restenosis was lower in patients
with type C/D dbsaction (W16, 37.5%) than type A/B (54/103, 52.4%) or no
dissection (166/295, 56.3%). Late MLD loss in type CID dissections (0.15
+ 0.66, n = 16) was also lower than that in type AJB dissections (0.63 +
0.67, n = 103, p = 0.009) or no dieaecfion (0.74 * 0.74, n = 295, p = 0.002).
Conokkdons:Type C & D dissections are associated with slower post PTCA
flow (~ CTFCS) and a higher risk of abrupt closure than type A & B or no
dissection, but with a lower risk of restenosis.
m9933 Incidence and management of coronary perforationin different coronary interventions
T. Fukutomi, T. Suzuki, H. Hosokawa, T. Tani. National ToyohashiFfigashi
Hospital, Toyohashi,Japan
The purpose of this study was to examine the incidence of coronary per-
foration (CP) complicating interventional procedures using either POBA or
New Devices, and to see the feasibility of developing management strategies
based on the nature of the perforation and their outcome. Angiographiedly,
CPdivided into two types: type 1characterized by epicardial ateining but with
no visible extravasating contrast jet, and type 2 with visible jet.
CP (“A) Type1 Type2 Tampo. Centssis PB CABG
POBA 2713,534 0.8 0.7 0.1 0.14 0.14 0,170
DCA 71376 1.9 0.3 1.6 1.3 1,3 1.6 0.3
Stent 5/366 1,4 0.6 0,5 1.1 l.t 0.5 0
Cuttina 6/538 1.1 0.4 0.7 0.4 0.4 0.9 0
ELCA- 3/13 23 23 0 0 0 23 0
Tempo:cardiactamponade,PB:perfusionballoon
Perforations complicating POBA were mostly type 1 and over one half of
the patients could be managed conservatively with intravenous hemostatic
agents, but type 2 complicated New Devices more frequently (POBA O.1%
vs. New Devices 0.9%, p < 0.0001). Because type 2 perforations often
progress to pericardial tamponade rapidly, all required pericardiocentesis.
The therapeutic strategy also included the use of the perfusion balloon
catheter, more often in type 2 perforations. By these procedures, there was
no death.
Conclusion: the risk of CP are increased “with the use of New Devices
compared to POBA, but in the great majority of patients, it could be managed
with perieardiocentesis, followed by catheter drainage in conjunction with
inflation of perfusion catheter.
H The Relationship Between Coronary Artery
Dissection and Long-term Clinical Outcome: Results
from the CRAC (Cornpliencs Related Acute
Complication) Trial
J.D. Talley,J. Blankenship, S. Wems, A. Spokojny, C. Landeau,
H.V.Anderson, H. White, R. Bach, R. Siegal, M. Krucoff, R. Raymond,
T. Little, T. Waites, S. Sharma, S. Warren, J. Bissett, C. Green, M. Rawert,
J. Pinkeston, M. Hope, for the CRAC investigators. UrrivofArkansaa, Litt/e
Rock, AR, USA
Coronaty artery dissection after elective PTCA may improve long-term pa-
tency and clinical status, if unaccompanied by complications. This relation-
ship was evaluated in the CRAC trial, a prospective, randomized study of
compliant (POC) and non-compliant (PET) balloon material in 1263 pts un-
dergoing elective PTCA at 35 centers. Dissection grade was determined by
the consensus of 2 of 3 reviawers. Clinical status was measured 6 months
after PTCA via postcard or phone cail.
No dissection Any dissection P
ER visit 25% 23% ns
Re-hoapitallzation 37% W“h ns
Ml 9% 8% ns
Re-Cath 25% 24% ns
CABG surgery 7% 10% na
Anginagrade 22 37% 34% ns
Hsaith Improved 76% 69% 0.0s
Thus: clinical status 6 months after eleorive’PTCA is not related to dis-
section of the coronary artery at the site of balloon dilatation.
~ Clinical, An~iOgraPhicand T~chnical~Orrela~SOf
Early Abrupt Vascular Closure During Coronary
Intervention
K.N. Garratt, D. Grill, M.R, Bell, P,B.Berger, D.R. Holmes, Jr.. Mayo C//rric,
Rochestec MN, USA
Alargeooronary intervention databank was interrogated to identify mrrelates
of in-hospital abrupt vaacular closure (AC). 592 pts with AC (TIMI grade O-1
blood flow) were identified. These pts were matched to 592 pts without AC
by age, gender, axtent of coronaty artey disease, and nearest procedure
date. Procedure type was categorized as balloon angioplaafy only (n =
1038 procedures), atherectomy (n = 91), laser angioplasty (n = 26), or
elective stent implantation (n = 27); patiants receiving stents to treat AC
were assignad to the procedure causing the AC event. Univariate analysis
identified myocardial infarction within 24 hra prior to procedure (P= 0.004),
emergency procedure (P= 0.026), and current cigarette smoking (P= 0.026)
as significant clinical correlates. Leaionthrombus (P = 0.0001) and angulation
(P= 0.02) were significant angiogrephic correlates; iesion calcification (P =
0.07) approached significance. Compared with all other devices combinad,
use of balloon angioplasty alone was associated with a significantly lower risk
of AC (P = 0.003). Relative to balloon angioptasty, an increased risk of AC
was found with atherectomy devices (odds ratio [OR] = 1.6, upper and lower
95% confidence intervals [Cl] = 1.16-2.8, P = 0.009) and laser devices (OR
=2.9, Cl= 1.2-7.0, P = 0.017) but elective corona~ stents neither increased
nor decreased AC risk (OR = 1.0, Cl = 0.46-2.14, P = 0.99). A multivariate
backward elimination regression model identified lesion thrombus (P = <
0.001), use of athereotomy devices (P= c 0.001), Iaserdevices (P = 0.004),
lesion angulation (P = 0.01) and cigarette smoking (P = 0.05) as correlates
of increased AC risk.
Conclusions: This large matched cohort study confirms discrete clinicai
and angiographic correlates of AC. Atherectomy and laser devices increase
AC risk, Elective stent implantation did not appear to reduce AC risk over
conventional balloon angioplasty; the small number of such pts studied may
have prevented any benefit from being observed.
=1 P~di~tO~Of~YOCardia,,nfarctiOn(~,]With
Percutaneous Revascularization in a Large
Multicenter Population
B.E. Tardiff, B. Mabe, N. Wildermann, M.H. Sketch, Jr., D.R. Holmes, Jr.,
E.M. Ohman, R.M. Califf. Duke Universi~ Durham, NC, USA
Percutaneous revascuiarization is often complicated by clinical or biochemi-
cal evidence of new myocardial necrosis. Certain patients may be at higher
riskforperi-procedural MIs, Reexamined demographic, clinical and anatomic
predictors of Mi in a pooied dataset of 6348 patients comprising 7 clinical
trials involving PTCA or DCA. 221 patients (4%) had an Ml on the same
day as the index intervention. Independent predictors of Ml after PTCA/OCA
were iimited to history of previous CABG, and graft identified as target vessel.
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Patientswith prior Ml, including recent Ml (within preceding 2 weeks), were
less likely to have peri-procedural infarctions.
Variable Ml n = 221 No Ml n = 6127 P
PreviousMl so (374A) 2822 (46”/.) 0.00s4
Recent Ml 32 (17%) 1075 (20”/0) 0.0049
No priorMl 136 (74%) 3304 (62%)
PreviousCABG 5S (27%) 669 (15”/6) 0.0001
No priorCABG 154 (73%) 3749 (650A)
Target graft lesion 40 (22%) 365 (6%) 0.0001
Targst native lesion 145 (76%) 5645 (94%)
Corrchsions: Patients with prior CABG undergoing percutaneous inter-
ventions were at high risk for procedural Mls. Interventions on grafts were
much more likely to be associated with Ml as interventions on native lesions.
Strategies directed at preventing pen-procedural Ml in these patients need
to be developed. A histoty of recent Ml was not a significant predictor of peri-
interventional events; in fact, in this sample, patients with prior infarctions
experienced fewer procedural infarctions.
n9937 Omission of Routine ECG and CK-Monitoring
Following Uncomplicated Coronary Angioplasty
L. Pizzulli, W. Kremer, M. Zirbes, W. Jung, B. Luderitz. Depatirnerrt of
CardiobgN UrriversityofBonn, Bonn, Gerrrrany
Thedifferent management of patients (pat) following PTCAinfluences hospital-
costs and in-hoapital stay. It includes often the monitoring of ECG and CK-
Ievels. In a proapectlve study we analyzed the influence of both parameters
on the clinical course after uncomplicated PTCA. We enrolled 600 pat re-
ferred foreleotive intervention. In all pat the ECG and CK were checked pre-,
immediately pa.t-PTCA and after 5 and 24 hours. A total of 98 pat were
excluded due to visible dissections ancflor thrombus. Thus, 502 pat fulfilled
the entry criteria for uncomplicated intervention. They were monitored clin-
ically and angina was assessed as non-present (0), mild and new onset in
comparison to pre-PTCA (l), chest pain requiring nitroglycerin (H)and severe
chest pain (Ill).
Reaulta:
o I II Ill
Angina (n=) 462 20 13 7
re-angio (n =) o 0 10 7
ST-changes (%) 4.5 6.5 7s 100
non-Q-wave-Ml (n=) o 0 3 4
The CK-levels increased from 38 +24 WI (pre-PTCA) to 29 +21 (pest-
PTCA), W *38 (after 5 h) and 47 &86 (after 24 h). A significant increase
occurred only in pat with symptomatic ischemia (11+ Ill). There were no
consequences in asymptomatic pts (0) despite ECG-changes occurring in
4.5%.
Corrc/uaiorr:The routine monitoring of ECG and CK-levels following suc-
cessful PTCA is omitfable since postprocedural therapeutic consequences
depend only on patients symptoms.
n9938 Upright Poeture With a Flexibie Femoral Sheath:Safety and Coet Results from 900 Patiente in the
“Heads Up” Trial
M.W. Krucoff, D.1.Landis, C.L. Green, A.K. Loeffler, E. Eisenstein,
A. Moore, J.E. Tctteng, R.M. Califf, D.B. Mark, K.G. Morris, M.H. Sketch, Jr..
Duke University Medical Centec Durbam, NC, USA, VAMedical Centar,
Durham, NC, USA
Femoral arteriotomy sites area source of added morbidity and cost in PTCR
patients. To assess safety and influence on cost of sitting up with a flexible
woven metal sheath (Arrow-Flex, Arrow) 900 (78%) of all eligible pts under-
going elective PTCR over I year were randomized to upright (head of bed
fjr)9) or supine (head of bed 3rJQ)position, stratified forsheathremoval=me
day (<12 Ma)or nextday(?12 hra).Sheathswere8 Fr in 98%, venous&
arterial in 17%, with Reopro usad in 31%. Costs (50th [25th, 75th %ile] in $)
of sedatives, narcotics, NSAIDS& anti-emetics (MEDS); labs, transfusions,
vascular X-rays, procedures & surgical consults (LAB.IWR), as well as inci-
dence (Y.)of all MAJOR (retro or groin bleed with PRBCS,fistulelaneutysm,
pulse loss) & MINOR (oozing, hematoma, bruit) vascular events from end,of
PTCR to 24 hrs after sheath pull were:
Parametsr <12 HRS suDine Umiaht >12 HRSsuoina Umiaht
#Prs 245 340 107 10s
MEDS 16 (11, 64) 16 (11, 59) 74 (66, 94) 73 (60, S9)
LABSiXR 103 (46, 134) 109 (47, 150) 121 (71, 195) 116 (60, 176)
ALL $$$ 122 (70, 192) 124 (77, 166) 204” (143, 2S5) 197* (135, 257)
MINOR 127 (37”/0) 131 (39%) 57 (53%) 84 (59%)
MAJOR 45 (13%) 45 (130/.) 17 (16°/0) 14 (13%)
*P= o.23 by Wilcoxon Rank Sum Teat
Thus: Upright posture with a flexible sheath was safe, and associated
with a trend to cost reduction in pt management.
w] prosP.ctiveueeofa~ r.utaneo.svas.uiar
Closure Device in Patients Undergoing PTCA and
Stenting: Single Center Experience
C. Loubeyre, C. Karam, J. Fajadet, C.’Jordan, B. Cassagneau,
J.-P, Laurent, J. Marco. Chrique Pasteur, Toulouse, Franca
In order to assess the safety and the efficacy of a suture mediated closure
of femoral access after PTCA, we carried out a prospective study in 232
patients (pts) from February to June 96. After a preliminary experience with
the device in 237 pts, providing the training period, showing a success rate
of 92%, hematoma in 3.4%, and vascular surgery in 2.1%, we conducted the
prospective study which included 182 males, 50 females, with a mean age of
63+ 10 years (36-84). Stents were implanted in 146 pts (63%). All pts were
fully anticoagulated attimeof sheath removal (mean aPTT:741 sac). Average
bolus heparin dose was 9600 units. In addition to heparin, all pts received
24 to 46 h Ticiopidine + ASA, 31 pts LMWH, and 5 pts c7E3 (ReoPro). Six
operators used Techstar 6F in 47, Techstar 8F in 88, Prostar Plus 8F in 95
and Prostar 9F in 2. Average time to achieve hemostasis was 10 + 4 min
(3-30), Immediate procedural succees was achieved in 212/232 pte (91.4%).
Complications included: hematoma in 15/232 (6.4%), false aneutysm in 5/232
(2.1%), infection in 1/232 (0.4%). These complications needed vascular
repair in 5/232 (2.1%): 3 were performed during the hospital phaee, and 2
were delayed. A mechanical compression was added in 53 pts. Average time
to ambulation was 12 hours (2-48). Mean time to discharge was 1.9 + 1
(l-7) days.
Conclusion: Despite high volume experience, the use of percutaneous
vascular surgery device following corona~ interventions in pts under full
anticoagulation and antiplatelet regimen is associated with vascular compli-
cations in 9% and vascular surgery in 2.1Yoof pts. Average time to ambulation
is obtained 12 h after procedure.
I993-1OIVaSCularACCeSSsite~OMp,iCatiOnSAfier
Percutaneous Coronary Intervention With
Glycoprotein lib/flia Receptor Inhibitor Therapy in
the EPiC Triai
J.C. Blankenship, A.S. Hellkamp, S.L. Demko, F.V.Aguirre, E.J. Topol,
R.M. Califf, for the EPIC Investigators. Gaisirrger A4edica/Centec Danvi//e,
PA, USA
We evaluated predictors of vascular accees cite (VAS) complications (comp)
of percutaneous coronary intervention (PC!) with vs. without the glycoprotein
llb/llla receptor inhibitor abciximab in the EPIC trial. Methods: 2099 patients
undergoing PCI were randomized to placebo vs abciximab bolus vs ab-
ciximab bolu?Jinfusion.Heparin continued after PCI for 12–16 hre; sheaths
were pulled >4 hrs after that. Predictors of VAS bleeding with drop in Hot >
10-12% or VAS surgical repair were identified with multivariate regression
analysis of 25 baseline and procedural variables. Rasu/ts: 18% of patients
had VAS comp. Predictors included in descending importance: abciximab
treatment, higher baseline Hct, longer time in cath lab, lower weight, female
sex (all p < 0.0001); PCI during Ml (p = 0.0005); higher in-lab ACT (p =
0.0027); advanced age (p = 0.0091); and larger sheath size (p = 0.0298).
VAS comp patients stayed longer in hospital post-PCl (median 4 ve 2 days,
p < 0.001). VAS comp rates across sitee ranged from 6% to 29% (median =
17%, interquaItile range 13%-21%). cOf7C/USiOIW: 1: Abciximab caused ex-
cess VAS comp. 2. Factors under operator control contribute to excess VAS
comp (procedure duration, heparin dosing leading to higher ACTS,sheath
size). 3. The wide variation in incidence of VAS comp across participating
centers may reflect differences in patient management. Identification of “best
practices” at centers with low comp rates may decrease overall VAS mmp
rates.
